Novartis OTCs Fit Well With Pharma Core - CFO
This article was originally published in The Tan Sheet
Executive Summary
Novartis' nutritional and eye care businesses are seen as "farther away" from the company's core pharmaceutical focus going forward, CFO Raymund Breu told a J.P. Morgan CEO conference on building shareholder value April 26.
You may also be interested in...
Novartis Consumer Health Reshuffled, Functional Foods On Sales Block
Novartis is reorganizing its consumer health division by grouping together three businesses - OTC drugs, infant and baby and medical nutrition - and operating animal health and Ciba Vision as separate units, the firm stated during a year-end analysts call Feb. 7
Novartis Consumer Health Reshuffled, Functional Foods On Sales Block
Novartis is reorganizing its consumer health division by grouping together three businesses - OTC drugs, infant and baby and medical nutrition - and operating animal health and Ciba Vision as separate units, the firm stated during a year-end analysts call Feb. 7
Novartis Consumer Health Reshuffled, Functional Foods On Sales Block
Novartis is reorganizing its consumer health division by grouping together three businesses - OTC drugs, infant and baby and medical nutrition - and operating animal health and Ciba Vision as separate units, the firm stated during a year-end analysts call Feb. 7